Have you read these stories?

How one builder took six banks and 30,000 homebuyers for a ride

Forensic audit of Unitech, done on SC's orders, reveal massive diversion of funds by the firm.


Jan 18, 2020, 06.17 PM IST



Biocon sees a sweet spot with its affordable insulin in US

The biotech firm is also planning to provide its rh-insulin to middle- and low-income countries at less than 10 cents a day. Biocon Biologics is chasing a revenue target of $1 billion in financial year 2021-22. In the previous fiscal year, its revenue had topped $200 million.

Fact-check: Diabetes is killing Indians; control your weight, diet to delay condition

By 2030, the number of people expected to suffer from T...

Volume with low cost is Biocon Biologics’ big plan

The Biocon subsidiary will chart a path that ensures high volumes and low costs, unlike co...

ET Prime Distribution
Load More...

Other useful Links

Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service